GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » By-health Co Ltd (SZSE:300146) » Definitions » Debt-to-EBITDA

By-health Co (SZSE:300146) Debt-to-EBITDA : 0.05 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is By-health Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

By-health Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥14 Mil. By-health Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥159 Mil. By-health Co's annualized EBITDA for the quarter that ended in Mar. 2024 was ¥3,592 Mil. By-health Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for By-health Co's Debt-to-EBITDA or its related term are showing as below:

SZSE:300146' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -4.27   Med: 0.05   Max: 0.81
Current: 0.1

During the past 13 years, the highest Debt-to-EBITDA Ratio of By-health Co was 0.81. The lowest was -4.27. And the median was 0.05.

SZSE:300146's Debt-to-EBITDA is ranked better than
92.65% of 1429 companies
in the Consumer Packaged Goods industry
Industry Median: 2.13 vs SZSE:300146: 0.10

By-health Co Debt-to-EBITDA Historical Data

The historical data trend for By-health Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

By-health Co Debt-to-EBITDA Chart

By-health Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.27 0.15 0.03 0.01 0.07

By-health Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.10 -0.25 0.05

Competitive Comparison of By-health Co's Debt-to-EBITDA

For the Packaged Foods subindustry, By-health Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


By-health Co's Debt-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, By-health Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where By-health Co's Debt-to-EBITDA falls into.



By-health Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

By-health Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(12.709 + 161.461) / 2447.669
=0.07

By-health Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(13.593 + 158.758) / 3592.384
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


By-health Co  (SZSE:300146) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


By-health Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of By-health Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


By-health Co (SZSE:300146) Business Description

Traded in Other Exchanges
N/A
Address
No. 19 Xinghan Road, Sanzao Technology Industrial Park, Jinwan District, Guangdong Province, Zhuhai City, CHN, 510663
By-health Co Ltd, formerly Guangdong By-Health Biotechnology Co., Ltd. develops, produces and sells nutritional supplements, functional health food, and natural dietary supplement products to help people improve their health and quality of life.

By-health Co (SZSE:300146) Headlines

No Headlines